

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 9.33749348 |
| 2 | white fat cell differentiation (GO:0050872) | 8.04700999 |
| 3 | brown fat cell differentiation (GO:0050873) | 7.90528296 |
| 4 | biotin metabolic process (GO:0006768) | 7.30640122 |
| 5 | valine metabolic process (GO:0006573) | 7.11458166 |
| 6 | * triglyceride catabolic process (GO:0019433) | 6.83373136 |
| 7 | fatty acid transmembrane transport (GO:1902001) | 6.37368901 |
| 8 | lipid particle organization (GO:0034389) | 6.24813251 |
| 9 | triglyceride biosynthetic process (GO:0019432) | 6.17023995 |
| 10 | transcytosis (GO:0045056) | 6.12745001 |
| 11 | * acylglycerol catabolic process (GO:0046464) | 6.04995539 |
| 12 | * neutral lipid catabolic process (GO:0046461) | 6.04995539 |
| 13 | positive regulation of fatty acid oxidation (GO:0046321) | 6.04838625 |
| 14 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 6.03595401 |
| 15 | neutral lipid biosynthetic process (GO:0046460) | 5.90671311 |
| 16 | acylglycerol biosynthetic process (GO:0046463) | 5.90671311 |
| 17 | carnitine shuttle (GO:0006853) | 5.89386581 |
| 18 | regulation of cholesterol storage (GO:0010885) | 5.86734221 |
| 19 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.75837725 |
| 20 | lipid storage (GO:0019915) | 5.54727517 |
| 21 | fatty acid beta-oxidation (GO:0006635) | 5.42557616 |
| 22 | response to dietary excess (GO:0002021) | 5.36427233 |
| 23 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 5.15867961 |
| 24 | branched-chain amino acid metabolic process (GO:0009081) | 4.92372378 |
| 25 | polyol transport (GO:0015791) | 4.84354501 |
| 26 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.83756417 |
| 27 | branched-chain amino acid catabolic process (GO:0009083) | 4.82389964 |
| 28 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.80283018 |
| 29 | regulation of fatty acid oxidation (GO:0046320) | 4.78114709 |
| 30 | fatty acid oxidation (GO:0019395) | 4.75770468 |
| 31 | acyl-CoA biosynthetic process (GO:0071616) | 4.75713117 |
| 32 | thioester biosynthetic process (GO:0035384) | 4.75713117 |
| 33 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.75146991 |
| 34 | coenzyme A biosynthetic process (GO:0015937) | 4.73964556 |
| 35 | carnitine transmembrane transport (GO:1902603) | 4.70137124 |
| 36 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.68086759 |
| 37 | lipid oxidation (GO:0034440) | 4.67064379 |
| 38 | ethanol oxidation (GO:0006069) | 4.64101091 |
| 39 | fatty acid catabolic process (GO:0009062) | 4.59897814 |
| 40 | * glycerolipid catabolic process (GO:0046503) | 4.51896633 |
| 41 | protein heterotrimerization (GO:0070208) | 4.49246101 |
| 42 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.42670583 |
| 43 | negative regulation of protein autophosphorylation (GO:0031953) | 4.32474603 |
| 44 | fatty acid homeostasis (GO:0055089) | 4.31828072 |
| 45 | carnitine transport (GO:0015879) | 4.28468608 |
| 46 | amino-acid betaine transport (GO:0015838) | 4.28468608 |
| 47 | * triglyceride metabolic process (GO:0006641) | 4.27906259 |
| 48 | ovulation from ovarian follicle (GO:0001542) | 4.27041862 |
| 49 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.26529653 |
| 50 | negative regulation of granulocyte differentiation (GO:0030853) | 4.22841706 |
| 51 | positive regulation of fatty acid metabolic process (GO:0045923) | 4.16877665 |
| 52 | acetyl-CoA metabolic process (GO:0006084) | 4.14707781 |
| 53 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.13766497 |
| 54 | negative regulation of lipid storage (GO:0010888) | 4.12686247 |
| 55 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.11820122 |
| 56 | negative regulation of phagocytosis (GO:0050765) | 4.08126117 |
| 57 | cellular response to lithium ion (GO:0071285) | 4.07636219 |
| 58 | positive regulation of lipid catabolic process (GO:0050996) | 4.06210170 |
| 59 | negative regulation of smooth muscle cell migration (GO:0014912) | 4.05604968 |
| 60 | negative regulation of amino acid transport (GO:0051956) | 4.05499102 |
| 61 | positive regulation of lipid storage (GO:0010884) | 4.05093286 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.04523393 |
| 63 | * acylglycerol metabolic process (GO:0006639) | 4.03602739 |
| 64 | regulation of gonadotropin secretion (GO:0032276) | 4.02235639 |
| 65 | response to phenylpropanoid (GO:0080184) | 4.00775862 |
| 66 | * neutral lipid metabolic process (GO:0006638) | 3.97966185 |
| 67 | glycerol metabolic process (GO:0006071) | 3.96878491 |
| 68 | NADH metabolic process (GO:0006734) | 3.96120299 |
| 69 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.93757997 |
| 70 | positive regulation of glomerulus development (GO:0090193) | 3.90864923 |
| 71 | cellular response to epinephrine stimulus (GO:0071872) | 3.89924999 |
| 72 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.87825598 |
| 73 | positive regulation of glucose import (GO:0046326) | 3.85791245 |
| 74 | intracellular lipid transport (GO:0032365) | 3.82672584 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.80389909 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.80389909 |
| 77 | tricarboxylic acid metabolic process (GO:0072350) | 3.79076658 |
| 78 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.77053606 |
| 79 | alpha-linolenic acid metabolic process (GO:0036109) | 3.74865751 |
| 80 | positive regulation of glycolytic process (GO:0045821) | 3.74135321 |
| 81 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.72895406 |
| 82 | pentose-phosphate shunt (GO:0006098) | 3.71485260 |
| 83 | response to epinephrine (GO:0071871) | 3.70048042 |
| 84 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.70000536 |
| 85 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.65324113 |
| 86 | positive regulation of cholesterol efflux (GO:0010875) | 3.65087464 |
| 87 | NADPH regeneration (GO:0006740) | 3.64832351 |
| 88 | diacylglycerol metabolic process (GO:0046339) | 3.63568118 |
| 89 | negative regulation of macrophage differentiation (GO:0045650) | 3.61794648 |
| 90 | primary alcohol metabolic process (GO:0034308) | 3.60995495 |
| 91 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.59991738 |
| 92 | cGMP-mediated signaling (GO:0019934) | 3.58387183 |
| 93 | regulation of lipid storage (GO:0010883) | 3.57157405 |
| 94 | coenzyme A metabolic process (GO:0015936) | 3.55734561 |
| 95 | glomerular filtration (GO:0003094) | 3.55346453 |
| 96 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.54470231 |
| 97 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.54089144 |
| 98 | ethanol metabolic process (GO:0006067) | 3.52560659 |
| 99 | positive regulation of cholesterol transport (GO:0032376) | 3.51993202 |
| 100 | positive regulation of sterol transport (GO:0032373) | 3.51993202 |
| 101 | regulation of receptor binding (GO:1900120) | 3.50686751 |
| 102 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.49829054 |
| 103 | regulation of lipoprotein metabolic process (GO:0050746) | 3.47399175 |
| 104 | negative regulation of gluconeogenesis (GO:0045721) | 3.47230243 |
| 105 | growth hormone receptor signaling pathway (GO:0060396) | 3.47147032 |
| 106 | negative regulation of metanephros development (GO:0072217) | 3.46989046 |
| 107 | oxaloacetate metabolic process (GO:0006107) | 3.46805710 |
| 108 | alditol metabolic process (GO:0019400) | 3.46557750 |
| 109 | tricarboxylic acid cycle (GO:0006099) | 3.43173480 |
| 110 | protein localization to cell surface (GO:0034394) | 3.42774938 |
| 111 | regulation of triglyceride catabolic process (GO:0010896) | 3.42008081 |
| 112 | monocarboxylic acid catabolic process (GO:0072329) | 3.41049203 |
| 113 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.40562392 |
| 114 | fat cell differentiation (GO:0045444) | 3.40087546 |
| 115 | L-serine transport (GO:0015825) | 3.37881671 |
| 116 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.37133856 |
| 117 | long-chain fatty acid transport (GO:0015909) | 3.37060254 |
| 118 | barbed-end actin filament capping (GO:0051016) | 3.35305589 |
| 119 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.34492164 |
| 120 | triglyceride homeostasis (GO:0070328) | 3.33450255 |
| 121 | acylglycerol homeostasis (GO:0055090) | 3.33450255 |
| 122 | phosphatidic acid biosynthetic process (GO:0006654) | 3.33092679 |
| 123 | phosphatidic acid metabolic process (GO:0046473) | 3.33092679 |
| 124 | retinol metabolic process (GO:0042572) | 3.32913783 |
| 125 | succinate metabolic process (GO:0006105) | 3.30042224 |
| 126 | cellular response to leptin stimulus (GO:0044320) | 3.26436280 |
| 127 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.25804857 |
| 128 | positive regulation of metanephros development (GO:0072216) | 3.22245722 |
| 129 | negative regulation of lipid catabolic process (GO:0050995) | 3.19975771 |
| 130 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.17091191 |
| 131 | renal filtration (GO:0097205) | 3.15161007 |
| 132 | endocrine hormone secretion (GO:0060986) | 3.13866907 |
| 133 | positive regulation of glucose transport (GO:0010828) | 3.13476721 |
| 134 | response to vitamin E (GO:0033197) | 3.12074060 |
| 135 | cellular response to vitamin (GO:0071295) | 3.11320717 |
| 136 | regulation of glomerulus development (GO:0090192) | 3.08285191 |
| 137 | response to hydroperoxide (GO:0033194) | 3.07890370 |
| 138 | angiogenesis involved in wound healing (GO:0060055) | 3.06488992 |
| 139 | low-density lipoprotein particle clearance (GO:0034383) | 10.0716960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 7.04314698 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.51529991 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.77424294 |
| 4 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.76294065 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42001999 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34077472 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32798731 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.31469200 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.28995199 |
| 10 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.27965709 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 16.1566593 |
| 12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.89606579 |
| 13 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.88223879 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85104013 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80437381 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79400565 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79110068 |
| 18 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.77371422 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76520377 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.64905977 |
| 21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.64405477 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63320563 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54939192 |
| 24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38364840 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37698501 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37661814 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30477564 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.26081897 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23457697 |
| 30 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23212846 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21523677 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19079129 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16347355 |
| 34 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16194974 |
| 35 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16194974 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15212113 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14694293 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13815218 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13625377 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10999909 |
| 41 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.10893396 |
| 42 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.09489043 |
| 43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09282599 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09156932 |
| 45 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08511006 |
| 46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07207614 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06802665 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06178802 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06142762 |
| 50 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.05105627 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04626071 |
| 52 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02954393 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99891582 |
| 54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99299129 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99150187 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98869148 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97699352 |
| 58 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93913778 |
| 59 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93321344 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92979875 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92763905 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91779958 |
| 63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91589910 |
| 64 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90633253 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90081546 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.89254907 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.89254907 |
| 68 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.88079454 |
| 69 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.87766621 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86876194 |
| 71 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.86368330 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85293406 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84484010 |
| 74 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.84054421 |
| 75 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83500253 |
| 76 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82787974 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82138419 |
| 78 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81121695 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80915063 |
| 80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79643404 |
| 81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79354837 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79354837 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78483069 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78047834 |
| 85 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77912920 |
| 86 | CBP_21632823_ChIP-Seq_H3396_Human | 0.77757809 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.76691065 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76356996 |
| 89 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.75569925 |
| 90 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.75569925 |
| 91 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.75569925 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75546171 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.73755005 |
| 94 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.73155702 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.71458985 |
| 96 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70846975 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70775335 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.70567986 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.70500373 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70278518 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.69503933 |
| 102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69446622 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69212894 |
| 104 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.68777387 |
| 105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.68094280 |
| 106 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.67800694 |
| 107 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.67695555 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67641730 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67549126 |
| 110 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.67120679 |
| 111 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66141657 |
| 112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.64727182 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64656276 |
| 114 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.62816339 |
| 115 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.62250799 |
| 116 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.61922786 |
| 117 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.61475719 |
| 118 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.58897081 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.58786244 |
| 120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.57311882 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56984064 |
| 122 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.55014673 |
| 123 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.54959276 |
| 124 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.54951731 |
| 125 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.54351852 |
| 126 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.53242060 |
| 127 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.53057530 |
| 128 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52873532 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.52416133 |
| 130 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.52250692 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.52174882 |
| 132 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.51760718 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.51647280 |
| 134 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.50636347 |
| 135 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.50440641 |
| 136 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.50440641 |
| 137 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.49942634 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49889262 |
| 139 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.49778458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 9.05104182 |
| 2 | MP0004130_abnormal_muscle_cell | 5.17946798 |
| 3 | * MP0005666_abnormal_adipose_tissue | 5.15739488 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 5.12177858 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.45929367 |
| 6 | * MP0005375_adipose_tissue_phenotype | 3.93977470 |
| 7 | MP0000013_abnormal_adipose_tissue | 3.55240278 |
| 8 | MP0002876_abnormal_thyroid_physiology | 3.28924210 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.24995643 |
| 10 | MP0000003_abnormal_adipose_tissue | 3.11277533 |
| 11 | * MP0002971_abnormal_brown_adipose | 3.10590921 |
| 12 | MP0005275_abnormal_skin_tensile | 2.89545862 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.77710895 |
| 14 | * MP0009115_abnormal_fat_cell | 2.59333652 |
| 15 | * MP0005334_abnormal_fat_pad | 2.50549965 |
| 16 | MP0005503_abnormal_tendon_morphology | 2.41552203 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.40582574 |
| 18 | MP0001661_extended_life_span | 2.26855032 |
| 19 | * MP0002970_abnormal_white_adipose | 2.19672977 |
| 20 | MP0003011_delayed_dark_adaptation | 2.09034402 |
| 21 | * MP0002118_abnormal_lipid_homeostasis | 1.95188143 |
| 22 | MP0003868_abnormal_feces_composition | 1.90901329 |
| 23 | * MP0005535_abnormal_body_temperature | 1.84710717 |
| 24 | MP0004272_abnormal_basement_membrane | 1.79408964 |
| 25 | MP0003724_increased_susceptibility_to | 1.79192121 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 1.71442051 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.61114509 |
| 28 | MP0003690_abnormal_glial_cell | 1.58104664 |
| 29 | MP0003186_abnormal_redox_activity | 1.55083242 |
| 30 | * MP0005452_abnormal_adipose_tissue | 1.44427058 |
| 31 | MP0003828_pulmonary_edema | 1.38563402 |
| 32 | MP0003279_aneurysm | 1.38283735 |
| 33 | * MP0003959_abnormal_lean_body | 1.36532285 |
| 34 | * MP0005448_abnormal_energy_balance | 1.34829201 |
| 35 | MP0000609_abnormal_liver_physiology | 1.26336908 |
| 36 | * MP0002078_abnormal_glucose_homeostasis | 1.25788713 |
| 37 | MP0006138_congestive_heart_failure | 1.23863090 |
| 38 | MP0001881_abnormal_mammary_gland | 1.21280096 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.18850126 |
| 40 | MP0002933_joint_inflammation | 1.14884377 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.13937751 |
| 42 | MP0003646_muscle_fatigue | 1.13863422 |
| 43 | MP0002060_abnormal_skin_morphology | 1.13727029 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.13502739 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.12635912 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.12202356 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.11649947 |
| 48 | MP0001727_abnormal_embryo_implantation | 1.11046347 |
| 49 | MP0005365_abnormal_bile_salt | 1.07306810 |
| 50 | MP0008775_abnormal_heart_ventricle | 1.04737387 |
| 51 | MP0003045_fibrosis | 1.04583987 |
| 52 | MP0000343_altered_response_to | 1.02448728 |
| 53 | MP0002796_impaired_skin_barrier | 0.99463894 |
| 54 | MP0000767_abnormal_smooth_muscle | 0.98853977 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 0.98118604 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 0.98031389 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 0.96368838 |
| 58 | MP0002254_reproductive_system_inflammat | 0.96002959 |
| 59 | MP0000750_abnormal_muscle_regeneration | 0.95116238 |
| 60 | MP0002006_tumorigenesis | 0.89149997 |
| 61 | MP0000751_myopathy | 0.88878695 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 0.88521802 |
| 63 | MP0005385_cardiovascular_system_phenoty | 0.88521802 |
| 64 | MP0005620_abnormal_muscle_contractility | 0.86319549 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85320347 |
| 66 | MP0005164_abnormal_response_to | 0.84637618 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.81095982 |
| 68 | MP0001764_abnormal_homeostasis | 0.80741820 |
| 69 | MP0004147_increased_porphyrin_level | 0.80271724 |
| 70 | MP0002332_abnormal_exercise_endurance | 0.80201378 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.80160417 |
| 72 | MP0004084_abnormal_cardiac_muscle | 0.79598362 |
| 73 | MP0004087_abnormal_muscle_fiber | 0.76745457 |
| 74 | MP0001756_abnormal_urination | 0.76591415 |
| 75 | MP0008961_abnormal_basal_metabolism | 0.76350413 |
| 76 | * MP0003948_abnormal_gas_homeostasis | 0.75075259 |
| 77 | * MP0003953_abnormal_hormone_level | 0.74750179 |
| 78 | MP0006276_abnormal_autonomic_nervous | 0.73788681 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.70901338 |
| 80 | MP0002168_other_aberrant_phenotype | 0.70529715 |
| 81 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69722189 |
| 82 | MP0001879_abnormal_lymphatic_vessel | 0.67706925 |
| 83 | MP0001177_atelectasis | 0.67681647 |
| 84 | * MP0000759_abnormal_skeletal_muscle | 0.66550112 |
| 85 | MP0000749_muscle_degeneration | 0.65708305 |
| 86 | MP0005508_abnormal_skeleton_morphology | 0.64524286 |
| 87 | MP0003075_altered_response_to | 0.62878019 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.59130619 |
| 89 | MP0002108_abnormal_muscle_morphology | 0.58754021 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 0.57634813 |
| 91 | MP0004036_abnormal_muscle_relaxation | 0.57599666 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.57302849 |
| 93 | MP0010630_abnormal_cardiac_muscle | 0.57211269 |
| 94 | MP0005332_abnormal_amino_acid | 0.57168453 |
| 95 | MP0004215_abnormal_myocardial_fiber | 0.56299190 |
| 96 | MP0002972_abnormal_cardiac_muscle | 0.56102301 |
| 97 | MP0005330_cardiomyopathy | 0.55916533 |
| 98 | MP0000427_abnormal_hair_cycle | 0.55360276 |
| 99 | MP0004858_abnormal_nervous_system | 0.55152512 |
| 100 | MP0003091_abnormal_cell_migration | 0.52994005 |
| 101 | MP0002133_abnormal_respiratory_system | 0.52665395 |
| 102 | MP0005388_respiratory_system_phenotype | 0.52665395 |
| 103 | MP0005266_abnormal_metabolism | 0.52181122 |
| 104 | MP0005165_increased_susceptibility_to | 0.52048095 |
| 105 | MP0009763_increased_sensitivity_to | 0.51251027 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.51126923 |
| 107 | MP0005369_muscle_phenotype | 0.51005236 |
| 108 | MP0001944_abnormal_pancreas_morphology | 0.50939219 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.50590675 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.50365453 |
| 111 | MP0009672_abnormal_birth_weight | 0.50341054 |
| 112 | MP0001614_abnormal_blood_vessel | 0.49223047 |
| 113 | MP0000249_abnormal_blood_vessel | 0.49202692 |
| 114 | MP0002128_abnormal_blood_circulation | 0.49087967 |
| 115 | MP0005647_abnormal_sex_gland | 0.48521870 |
| 116 | MP0005397_hematopoietic_system_phenotyp | 0.46261415 |
| 117 | MP0002139_abnormal_hepatobiliary_system | 0.46217044 |
| 118 | MP0001958_emphysema | 0.45017011 |
| 119 | MP0001853_heart_inflammation | 0.44291190 |
| 120 | MP0002009_preneoplasia | 0.43867882 |
| 121 | MP0003448_altered_tumor_morphology | 0.43021511 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.41304886 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.39968888 |
| 124 | MP0000858_altered_metastatic_potential | 0.38954735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 6.46476794 |
| 2 | * Acanthosis nigricans (HP:0000956) | 6.35867805 |
| 3 | * Hypertriglyceridemia (HP:0002155) | 5.59226172 |
| 4 | Protrusio acetabuli (HP:0003179) | 5.41922885 |
| 5 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.26844737 |
| 6 | Abnormality of glycine metabolism (HP:0010895) | 5.12569299 |
| 7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.12569299 |
| 8 | * Oligomenorrhea (HP:0000876) | 4.84686457 |
| 9 | Myoglobinuria (HP:0002913) | 4.57427674 |
| 10 | Long foot (HP:0001833) | 4.52739380 |
| 11 | Difficulty running (HP:0009046) | 4.29733944 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.11637935 |
| 13 | Complement deficiency (HP:0004431) | 4.10821387 |
| 14 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.97536645 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.90108544 |
| 16 | Increased muscle lipid content (HP:0009058) | 3.88714924 |
| 17 | Pigmentary retinal degeneration (HP:0001146) | 3.88284074 |
| 18 | Insulin resistance (HP:0000855) | 3.83893428 |
| 19 | Abnormality of proline metabolism (HP:0010907) | 3.81526521 |
| 20 | Hydroxyprolinuria (HP:0003080) | 3.81526521 |
| 21 | Rhabdomyolysis (HP:0003201) | 3.75225243 |
| 22 | Bone cyst (HP:0012062) | 3.72670359 |
| 23 | Growth hormone excess (HP:0000845) | 3.72422585 |
| 24 | Increased connective tissue (HP:0009025) | 3.68791687 |
| 25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.54582178 |
| 26 | Vertebral compression fractures (HP:0002953) | 3.46040841 |
| 27 | Thyroid-stimulating hormone excess (HP:0002925) | 3.42741203 |
| 28 | Aortic aneurysm (HP:0004942) | 3.35724541 |
| 29 | Ketoacidosis (HP:0001993) | 3.35496604 |
| 30 | Hemorrhage of the eye (HP:0011885) | 3.33451300 |
| 31 | Dicarboxylic aciduria (HP:0003215) | 3.32485235 |
| 32 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.32485235 |
| 33 | Subcapsular cataract (HP:0000523) | 3.32178457 |
| 34 | Back pain (HP:0003418) | 3.31259090 |
| 35 | Nausea (HP:0002018) | 3.30507740 |
| 36 | Polycythemia (HP:0001901) | 3.28318232 |
| 37 | Hyperthyroidism (HP:0000836) | 3.28049737 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 3.26878486 |
| 39 | Large hands (HP:0001176) | 3.18348220 |
| 40 | Ectopia lentis (HP:0001083) | 3.15173578 |
| 41 | Epidermoid cyst (HP:0200040) | 3.09784422 |
| 42 | Ketosis (HP:0001946) | 3.08387537 |
| 43 | Axonal loss (HP:0003447) | 3.06844271 |
| 44 | Ankle contracture (HP:0006466) | 3.01814093 |
| 45 | Hyperpituitarism (HP:0010514) | 3.01043750 |
| 46 | Hyperglycinemia (HP:0002154) | 2.99676822 |
| 47 | Multiple enchondromatosis (HP:0005701) | 2.98867115 |
| 48 | Myocardial infarction (HP:0001658) | 2.94519938 |
| 49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.90570908 |
| 50 | Broad metatarsal (HP:0001783) | 2.88914447 |
| 51 | Abnormality of complement system (HP:0005339) | 2.87422731 |
| 52 | Striae distensae (HP:0001065) | 2.86516859 |
| 53 | Colitis (HP:0002583) | 2.85961121 |
| 54 | Pancreatitis (HP:0001733) | 2.82154266 |
| 55 | Type 1 muscle fiber predominance (HP:0003803) | 2.81383367 |
| 56 | Cervical subluxation (HP:0003308) | 2.72795831 |
| 57 | Hyperammonemia (HP:0001987) | 2.72398442 |
| 58 | Spinal rigidity (HP:0003306) | 2.67665790 |
| 59 | Follicular hyperkeratosis (HP:0007502) | 2.67198518 |
| 60 | Prenatal maternal abnormality (HP:0002686) | 2.67083636 |
| 61 | Accelerated skeletal maturation (HP:0005616) | 2.65057666 |
| 62 | Shallow orbits (HP:0000586) | 2.64578487 |
| 63 | Cerebral aneurysm (HP:0004944) | 2.64377407 |
| 64 | Ileus (HP:0002595) | 2.63884229 |
| 65 | Facial diplegia (HP:0001349) | 2.62859265 |
| 66 | Lymphangioma (HP:0100764) | 2.60197850 |
| 67 | Frequent falls (HP:0002359) | 2.59050144 |
| 68 | Neck muscle weakness (HP:0000467) | 2.55656081 |
| 69 | Hyperlipoproteinemia (HP:0010980) | 2.49733440 |
| 70 | Vascular tortuosity (HP:0004948) | 2.48505577 |
| 71 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.47276608 |
| 72 | Abnormality of alanine metabolism (HP:0010916) | 2.47276608 |
| 73 | Hyperalaninemia (HP:0003348) | 2.47276608 |
| 74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.45034875 |
| 75 | Tetraparesis (HP:0002273) | 2.43139147 |
| 76 | Prominent supraorbital ridges (HP:0000336) | 2.42478108 |
| 77 | Toxemia of pregnancy (HP:0100603) | 2.39474683 |
| 78 | Muscle fiber splitting (HP:0003555) | 2.39187447 |
| 79 | Decreased subcutaneous fat (HP:0001002) | 2.38280842 |
| 80 | Wormian bones (HP:0002645) | 2.33812859 |
| 81 | Infantile muscular hypotonia (HP:0008947) | 2.33174251 |
| 82 | Limb hypertonia (HP:0002509) | 2.32741909 |
| 83 | Hepatic necrosis (HP:0002605) | 2.32274222 |
| 84 | Generalized aminoaciduria (HP:0002909) | 2.27639286 |
| 85 | Skin nodule (HP:0200036) | 2.27613545 |
| 86 | Abnormal eating behavior (HP:0100738) | 2.27494138 |
| 87 | Pulmonary artery stenosis (HP:0004415) | 2.24212352 |
| 88 | Abnormal cartilage morphology (HP:0002763) | 2.23616472 |
| 89 | Dilatation of the ascending aorta (HP:0005111) | 2.21723824 |
| 90 | Mitral valve prolapse (HP:0001634) | 2.19615546 |
| 91 | Hyperglycemia (HP:0003074) | 2.19061124 |
| 92 | Muscle stiffness (HP:0003552) | 2.18858361 |
| 93 | Premature rupture of membranes (HP:0001788) | 2.18672032 |
| 94 | Easy fatigability (HP:0003388) | 2.18071619 |
| 95 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.17688236 |
| 96 | Gowers sign (HP:0003391) | 2.16202850 |
| 97 | Renal cortical cysts (HP:0000803) | 2.15207131 |
| 98 | Increased serum pyruvate (HP:0003542) | 2.14143839 |
| 99 | Esophageal varix (HP:0002040) | 2.13624143 |
| 100 | Clitoromegaly (HP:0000057) | 2.13507383 |
| 101 | Slender build (HP:0001533) | 2.13491714 |
| 102 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.10293617 |
| 103 | Enlarged penis (HP:0000040) | 2.10088967 |
| 104 | Polar cataract (HP:0010696) | 2.09505726 |
| 105 | Polygenic inheritance (HP:0010982) | 2.08701737 |
| 106 | Neonatal hypoglycemia (HP:0001998) | 2.07190536 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 2.04469750 |
| 108 | Testicular atrophy (HP:0000029) | 2.03487871 |
| 109 | Polyphagia (HP:0002591) | 2.01736966 |
| 110 | Xanthomatosis (HP:0000991) | 2.01603294 |
| 111 | Proximal amyotrophy (HP:0007126) | 2.00839245 |
| 112 | Joint hemorrhage (HP:0005261) | 2.00757655 |
| 113 | Hypercholesterolemia (HP:0003124) | 2.00749442 |
| 114 | Abnormality of the periventricular white matter (HP:0002518) | 2.00502114 |
| 115 | Venous abnormality (HP:0002624) | 1.99999282 |
| 116 | Abnormal hemoglobin (HP:0011902) | 1.96395182 |
| 117 | Fibular hypoplasia (HP:0003038) | 1.96162574 |
| 118 | Autoimmune thrombocytopenia (HP:0001973) | 1.94486614 |
| 119 | Arterial tortuosity (HP:0005116) | 1.94347752 |
| 120 | Systemic lupus erythematosus (HP:0002725) | 1.93918635 |
| 121 | Prolonged bleeding time (HP:0003010) | 1.93560607 |
| 122 | Myotonia (HP:0002486) | 1.93390416 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.92693931 |
| 124 | Hyporeflexia of lower limbs (HP:0002600) | 1.92553414 |
| 125 | Soft skin (HP:0000977) | 1.91293945 |
| 126 | Gonadotropin excess (HP:0000837) | 1.91147214 |
| 127 | Conjunctival hamartoma (HP:0100780) | 1.88314817 |
| 128 | Abnormality of glycolysis (HP:0004366) | 1.87778577 |
| 129 | Atrioventricular block (HP:0001678) | 1.86398762 |
| 130 | Hypercortisolism (HP:0001578) | 1.86054849 |
| 131 | Aortic dissection (HP:0002647) | 1.86026778 |
| 132 | Gastrointestinal dysmotility (HP:0002579) | 1.83510383 |
| 133 | Hypoplasia of the iris (HP:0007676) | 1.83314984 |
| 134 | Turricephaly (HP:0000262) | 1.82627439 |
| 135 | Aneurysm (HP:0002617) | 1.80878769 |
| 136 | Foot dorsiflexor weakness (HP:0009027) | 1.80765694 |
| 137 | Megalocornea (HP:0000485) | 1.79321720 |
| 138 | Glucose intolerance (HP:0000833) | 1.79081037 |
| 139 | Overgrowth (HP:0001548) | 1.78520258 |
| 140 | Mutism (HP:0002300) | 1.78418882 |
| 141 | Aortic valve stenosis (HP:0001650) | 1.74664048 |
| 142 | Amyloidosis (HP:0011034) | 1.73801909 |
| 143 | Glomerulonephritis (HP:0000099) | 1.73731156 |
| 144 | Abnormality of serum amino acid levels (HP:0003112) | 1.73343382 |
| 145 | Nuclear cataract (HP:0100018) | 1.72510977 |
| 146 | Scapular winging (HP:0003691) | 1.71736486 |
| 147 | Coxa vara (HP:0002812) | 1.71199208 |
| 148 | Abnormal platelet volume (HP:0011876) | 1.70901275 |
| 149 | Spinal cord lesions (HP:0100561) | 1.70331004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 7.31973785 |
| 2 | CAMK1G | 5.32162832 |
| 3 | TRIB3 | 5.15673053 |
| 4 | SIK1 | 4.44700052 |
| 5 | BCKDK | 4.37147488 |
| 6 | PDK3 | 3.17566456 |
| 7 | PDK4 | 3.17566456 |
| 8 | TESK1 | 2.49756825 |
| 9 | LMTK2 | 2.48938867 |
| 10 | RIPK1 | 2.23856197 |
| 11 | MST1R | 2.23446259 |
| 12 | PRKAA2 | 2.10506496 |
| 13 | INSRR | 2.09647984 |
| 14 | PDK2 | 1.90687357 |
| 15 | ERN1 | 1.82440190 |
| 16 | CDK9 | 1.74857764 |
| 17 | EEF2K | 1.72466118 |
| 18 | GRK5 | 1.68780335 |
| 19 | FGFR3 | 1.63597142 |
| 20 | FRK | 1.62762311 |
| 21 | FGFR2 | 1.55372277 |
| 22 | MAP3K13 | 1.48318475 |
| 23 | RIPK4 | 1.37713128 |
| 24 | ARAF | 1.33972675 |
| 25 | PIK3CA | 1.31031945 |
| 26 | IRAK3 | 1.23886897 |
| 27 | EPHB2 | 1.22475556 |
| 28 | MOS | 1.20493490 |
| 29 | CDK6 | 1.18994096 |
| 30 | PDGFRA | 1.18478032 |
| 31 | TIE1 | 1.13815774 |
| 32 | JAK1 | 1.07914736 |
| 33 | TGFBR2 | 1.06840501 |
| 34 | MAP2K1 | 1.02487434 |
| 35 | MAP3K6 | 1.00628788 |
| 36 | PRKAA1 | 1.00370161 |
| 37 | KIT | 0.99708830 |
| 38 | PRKD3 | 0.97796793 |
| 39 | FES | 0.95768641 |
| 40 | LATS1 | 0.95688835 |
| 41 | ADRBK1 | 0.95202209 |
| 42 | KDR | 0.87582691 |
| 43 | TYK2 | 0.86840022 |
| 44 | PHKG2 | 0.86553290 |
| 45 | PHKG1 | 0.86553290 |
| 46 | MET | 0.85643874 |
| 47 | EIF2AK2 | 0.85264893 |
| 48 | PDPK1 | 0.85051870 |
| 49 | MAPK7 | 0.83978587 |
| 50 | STK38L | 0.81708455 |
| 51 | DDR2 | 0.78835350 |
| 52 | PRKCH | 0.77639036 |
| 53 | CDC42BPA | 0.76974099 |
| 54 | NEK9 | 0.76868500 |
| 55 | FGFR4 | 0.75149200 |
| 56 | PRKG1 | 0.74348967 |
| 57 | CAMK1 | 0.72986812 |
| 58 | PTK2 | 0.72230506 |
| 59 | PRPF4B | 0.71840369 |
| 60 | CAMKK2 | 0.71714886 |
| 61 | FER | 0.71140320 |
| 62 | JAK2 | 0.69050983 |
| 63 | PDK1 | 0.66270247 |
| 64 | PKN1 | 0.65369721 |
| 65 | MYLK | 0.65151454 |
| 66 | IGF1R | 0.64240375 |
| 67 | PINK1 | 0.62168792 |
| 68 | MTOR | 0.59137715 |
| 69 | JAK3 | 0.58031328 |
| 70 | MAPK11 | 0.57724045 |
| 71 | TNK2 | 0.56930654 |
| 72 | TTN | 0.55998152 |
| 73 | GSK3A | 0.55987147 |
| 74 | KSR2 | 0.55809910 |
| 75 | LATS2 | 0.55606941 |
| 76 | PDGFRB | 0.54762170 |
| 77 | PRKACB | 0.52586026 |
| 78 | IRAK1 | 0.52072166 |
| 79 | PRKD2 | 0.51911659 |
| 80 | CDK4 | 0.51537132 |
| 81 | ILK | 0.50294329 |
| 82 | RPS6KB1 | 0.47918327 |
| 83 | PTK2B | 0.47880389 |
| 84 | TBK1 | 0.47469209 |
| 85 | INSR | 0.47250361 |
| 86 | PRKD1 | 0.46668133 |
| 87 | * PRKACG | 0.46435046 |
| 88 | TYRO3 | 0.46141487 |
| 89 | STK38 | 0.44754272 |
| 90 | IRAK2 | 0.44697468 |
| 91 | RET | 0.43928930 |
| 92 | PAK4 | 0.43683660 |
| 93 | PKN2 | 0.43574085 |
| 94 | MAP3K7 | 0.43274136 |
| 95 | FGFR1 | 0.40585634 |
| 96 | YES1 | 0.40560060 |
| 97 | FLT3 | 0.40096048 |
| 98 | AKT2 | 0.39004121 |
| 99 | PRKG2 | 0.38954305 |
| 100 | CSF1R | 0.37688315 |
| 101 | DAPK3 | 0.37532083 |
| 102 | GRK1 | 0.36839897 |
| 103 | MAP3K1 | 0.36605453 |
| 104 | MARK2 | 0.36452154 |
| 105 | CLK1 | 0.36415645 |
| 106 | PAK2 | 0.36379178 |
| 107 | HIPK2 | 0.36060673 |
| 108 | BMX | 0.35813437 |
| 109 | MAPK1 | 0.33728868 |
| 110 | DMPK | 0.32092312 |
| 111 | ZAP70 | 0.31813879 |
| 112 | CAMKK1 | 0.31376745 |
| 113 | CSK | 0.31115774 |
| 114 | SRC | 0.30601375 |
| 115 | ABL2 | 0.30259448 |
| 116 | MAPKAPK5 | 0.30111984 |
| 117 | MAPK12 | 0.26969800 |
| 118 | AKT1 | 0.25128031 |
| 119 | STK11 | 0.24732179 |
| 120 | EPHA3 | 0.24534108 |
| 121 | ABL1 | 0.23099670 |
| 122 | MAP2K3 | 0.23072394 |
| 123 | STK3 | 0.20387149 |
| 124 | TEC | 0.19654418 |
| 125 | TRPM7 | 0.17708608 |
| 126 | DAPK2 | 0.15955779 |
| 127 | MAPK3 | 0.15476252 |
| 128 | SGK3 | 0.14268442 |
| 129 | EPHB1 | 0.13592413 |
| 130 | MAP2K4 | 0.13234522 |
| 131 | ICK | 0.12371703 |
| 132 | MAPK4 | 0.12031962 |
| 133 | MAPKAPK3 | 0.10281911 |
| 134 | OBSCN | 0.09685410 |
| 135 | NLK | 0.09369062 |
| 136 | PRKCE | 0.09209737 |
| 137 | CDK5 | 0.08693390 |
| 138 | * PRKACA | 0.08481451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.30793724 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.97521908 |
| 3 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 4.17158680 |
| 4 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.17036490 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.03164499 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.79906465 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.78919436 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.16693818 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.08052878 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.67248752 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.37709066 |
| 12 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.26156243 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19362298 |
| 14 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.12732333 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.12329829 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.81426515 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.80811280 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.74959938 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.51851578 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51034471 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48324573 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32113781 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.30510018 |
| 24 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.30406743 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.19809978 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19296497 |
| 27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09224636 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03119889 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02336406 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01559439 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01325153 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00853620 |
| 33 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00398788 |
| 34 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.98413120 |
| 35 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.94100613 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 0.90254230 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85633351 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85038729 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84740376 |
| 40 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81162299 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80847544 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75032162 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74774104 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70823206 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64413513 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.59731101 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59337284 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58966808 |
| 49 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55650096 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54823698 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53249383 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52259440 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51933903 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51348236 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48612347 |
| 56 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47328801 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44658910 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.44193611 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43968563 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43727766 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43534843 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.41870358 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40312308 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37727087 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36469306 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35014864 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32821204 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32817933 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30304473 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29566487 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28720390 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28451368 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.28234916 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28049772 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.27888718 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27523379 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27156350 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27142645 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27141516 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.25999407 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25662092 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23595502 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.23452394 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23066711 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.22699481 |
| 86 | Melanogenesis_Homo sapiens_hsa04916 | 0.21571786 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21521339 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21260529 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20354874 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19428318 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18675994 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.18481502 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.18431354 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.16949952 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.16666264 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.16344393 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16293882 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.16245731 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.15972013 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.15763689 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15735996 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.15083844 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.14735862 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13906146 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.12205803 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12080014 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11431677 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11087543 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.11075883 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.10940511 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.10803974 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.09356876 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.08665733 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.07609840 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07375422 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.06940195 |
| 117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.06858567 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.06150031 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05178595 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.04549562 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.04373457 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03934171 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03139010 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02677214 |
| 125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.02099767 |
| 126 | Malaria_Homo sapiens_hsa05144 | 0.01206732 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.01167157 |
| 128 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00166886 |
| 129 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0208500 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | -0.0114056 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0064567 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | -0.0028651 |

